Q3 FY2026 · ended Sep 30, 2026 · Revenue $1.95B, -7.0% YoY · Filed Nov 5, 2026
Solventum Corporation (SOLV) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $1.9 billion and a net loss of $12.0 million. Free cash flow was $97.0 million. As of Sep 30, 2026 it held $451.0 million in cash and investments and $5.3 billion in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SOLV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eagan, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1964738
- Former names
- 3M Health Care Co (until Feb 9, 2024)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.2B | $2.0B | $2.0B | $2.1B |
| Operating income | $68.0M | $181.0M | $81.0M | $124.0M | $1.7B |
| Net income | -$12.0M | $92.0M | $13.0M | $63.0M | $1.3B |
| Diluted EPS | -$0.07 | $0.53 | $0.07 | $0.36 | $7.22 |
| Operating cash flow | $177.0M | $227.0M | -$189.0M | $95.0M | $76.0M |
| Free cash flow | $97.0M | $144.0M | -$273.0M | $32.0M | -$21.0M |
| Total assets | $14.2B | $14.2B | $14.1B | $14.3B | $14.0B |
| Total liabilities | $9.4B | $9.4B | $9.1B | $9.2B | $9.0B |
| Stockholders' equity | $4.8B | $4.8B | $5.0B | $5.0B | $5.0B |
| Cash and investments | $451.0M | $403.0M | $561.0M | $878.0M | $1.6B |
| Total debt | $5.3B | $5.3B | $5.3B | $5.2B | $5.1B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2026 | Jul 16, 2026 |
All 263 Solventum Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.